Clinical Trials Logo

Filter by:
NCT ID: NCT02591264 Not yet recruiting - Coronary Thrombosis Clinical Trials

Periprocedural Myocardial Infarction: the Role of Human Neutrophil Peptide-1 to 3

Start date: November 2015
Phase: N/A
Study type: Observational

The aim of this study is to determine the role of human neutrophil peptide-1 to 3 in the occurrence of periprocedural myocardial infarction.

NCT ID: NCT02590770 Completed - Phobia, Social Clinical Trials

Gaze Contingent Feedback in Social Anxiety Disorder

Start date: October 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether giving gaze-contingent feedback is an effective attention modification procedure, helping in the treatment of social anxiety disorder (SAD)

NCT ID: NCT02588807 Withdrawn - Clinical trials for Amyotrophic Lateral Sclerosis

Food Supplement for the Treatment of Patients With Amyotrophic Lateral Sclerosis

ALS-PHL
Start date: January 1, 2021
Phase: Phase 1
Study type: Interventional

The purpose of the study is to evaluate the safety of combining phospholipids with medicinal plants for treatment of patients with amyotrophic lateral sclerosis (ALS)

NCT ID: NCT02587949 Recruiting - Clinical trials for Cerebrovascular Stroke

The Correlation Between Hair Cortisol Level of Acute Stroke or Its Long Term Disability.

Start date: November 2015
Phase:
Study type: Observational

In patients admitted to hospital with acute cerebrovascular stroke, we want to study the relationship between hair cortisol levels and biomarkers of inflammation and the clinical and radiological severity of the stroke and the degree of neurological disability being tested in three months and one year after.

NCT ID: NCT02586155 Completed - Clinical trials for Coronary Artery Disease

Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD

BETonMACE
Start date: November 2015
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether bromodomain extraterminal domain (BET) inhibition treatment with RVX000222 in high-risk type 2 diabetes mellitus patients with coronary artery disease increases the time to major adverse cardiovascular events.

NCT ID: NCT02585960 Completed - Hemophilia A Clinical Trials

BAX 855 PK-guided Dosing

PROPEL
Start date: November 23, 2015
Phase: Phase 3
Study type: Interventional

1. To compare the efficacy and safety of pharmacokinetic (PK)-guided treatment with BAX 855 targeting FVIII trough levels of 1-3% and approximately 10% (8-12%) 2. To further characterize pharmacokinetic (PK) and pharmacodynamic (PD) parameters of BAX 855

NCT ID: NCT02584972 Completed - Clinical trials for Autism Spectrum Disorder

Postural Control During Walking and Standing Among Children With Autism Spectrum Disorder

PCASD
Start date: November 2015
Phase:
Study type: Observational

Lately, many researchers have found that Children with autism spectrum disorder (ASD) are most likely to have gross motor deficiencies such as lack of coordination in gait and balance. Much has been researched on etiology and motor learning, but only very few researches have examined and analyzed quantitatively gait and balance in ASD. The aim of this research is to analyze quantitatively balance, gait and balance during perturbation in children with ASD and to compare with typically developed children (TD). A group of 20 children diagnosed with ASD and a control group of 20 TD children will be recruited and tested in the laboratory with well-established measures of gait and balance function. They will be instructed to stand as still as possible on a force plate with different task conditions : (1) standing with the eyes open (EO) - standing upright viewing an "X" displayed on a screen 3 meters in front of them; (2) eyes closed (EC) - same as (1) with the eyes closed and covered by blindfolds (i.e. no visual information). (3) Same as 1 standing on foam (i.e., conflicting proprioceptive information). Gait will be measured using the narrow base walk test, modified for clinical use. Participants will be asked to walk within a narrow path 6 meters long . The statistical analysis will include Independent T-tests to compare the ASD and controls with respect to different characteristics. General Linear Model (GLM) will be used by applying a separate model where the dependent variables will be the average values of the postural stability or gait stability parameters (continuous) and the independent variables were categorical by the group and task condition.

NCT ID: NCT02584959 Completed - Clinical trials for Hereditary Angioedema (HAE)

Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1 Esterase Inhibitor for the Prevention of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema

Start date: November 1, 2015
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the efficacy and safety of subcutaneous administration of a liquid formulation of C1 esterase inhibitor for the prevention of angioedema attacks in adolescent and adult subjects with hereditary angioedema.

NCT ID: NCT02583724 Recruiting - Depression Clinical Trials

Evaluation of Use of Brain Activity Monitoring for Evaluation of Depression Treatment Efficacy

Start date: September 2015
Phase: N/A
Study type: Interventional

This study evaluates the use of brain activity monitoring for early identification of pharmaceutical treatment efficacy and development of depression deterioration events.

NCT ID: NCT02583581 Recruiting - Migraine Clinical Trials

Evaluation of Use of Brain Activity Monitoring for Prediction of Migraine Attacks

Start date: October 2015
Phase: N/A
Study type: Interventional

This study evaluates the use of brain activity monitoring for prediction of migraine attacks in an expected time scale of 12-48 hours prior to the migraine attack.